Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967914 · ClinicalTrials.gov registry record
PVI for Prediction of Spinal Induced Hypotension
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 38
- Enrollment target
NCT01967914: Completed study, sponsored by Duke University.
NCT01967914 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01967914 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The hypothesis is that plethysmography variability index can predict the occurrence of hypotension after spinal anesthesia for cesarean delivery
Primary Outcome
Correlation between baseline PVI and change in SBP from baseline.
Interventions
- OTHER PVI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-01 |
What the finished NCT01967914 record still lists
NCT01967914 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PVI is the first listed.
NCT01967914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01967914 about?
NCT01967914 is a clinical study titled "PVI for Prediction of Spinal Induced Hypotension". The hypothesis is that plethysmography variability index can predict the occurrence of hypotension after spinal anesthesia for cesarean delivery
What is the current status of trial NCT01967914?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2013-10. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01967914?
The interventions under investigation include: PVI (OTHER).
Who is sponsoring clinical trial NCT01967914?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia